EBS

Emergent Biosolutions, Inc.

4.71 USD
-0.05 (-1.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Emergent Biosolutions, Inc. stock is up 149.21% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 17 May’s closed higher than April. In the last 9 Unusual Options Trades, there were 2 PUTs, 7 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Apr 15:24 21 Jun, 2024 5.00 PUT 100 437
02 May 14:37 20 Sep, 2024 2.50 CALL 220 442
07 May 14:07 20 Dec, 2024 7.50 CALL 450 42
08 May 17:17 21 Jun, 2024 5.00 CALL 500 1840
08 May 17:24 20 Dec, 2024 5.00 CALL 331 274
20 May 13:36 20 Dec, 2024 5.00 PUT 450 166
21 May 17:40 21 Jun, 2024 1.50 CALL 200 210
22 May 18:48 19 Jul, 2024 2.50 CALL 300 3
28 May 17:20 20 Sep, 2024 2.00 CALL 100 912

About Emergent Biosolutions, Inc.

Emergent BioSolutions focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose.